Crescent Capital Partners

Investor type

PE

Founded

2000

AUM

$4 500 M

Location

Sydney, New South Wales, Australia

Investment Ticket

$100+ m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

Australia and others
Investor profile last updated: 16 August, 2026

Profile

Crescent Capital Partners (Crescent) is one of the oldest and most successful Australian-based private equity and alternative asset firms. Founded in 2000, Crescent began as a private equity firm focused on mid-market ‘growth buy-out’ transactions and is today an alternative asset manager continuing to cover Australian and New Zealand private equity but also offering private credit and active listed equities fund products.
As a private equity manager, Crescent is a top quartile global fund manager (as measured by Cambridge Associates benchmarks) with a strong track record in delivering superior returns to investors that is the hallmark of its success to date. Crescent has closed multiple funds since its inception with total capital raised in excess of A$4.5 billion.
Crescent is well known for its deep experience and skill set in investing into healthcare, industrial, financial and services businesses, and we use this expertise and deep sector knowledge to inform investment decisions. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made over the past 10 years.
Crescent is offering wholesale investors access to its various funds through direct investment and via recognised wealth platforms.

Industry

Consumer Products Education Financial Services Healthcare Services Industrial Other Fintech Food and Beverage Foodtech Energy HealthTech

Crescent Capital Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Crescent Capital Partners Fund VI
Private Equity (PE)
Food and Beverage
Foodtech
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
Australia and others
$5-10 m
$529 M
August 2018
Crescent Capital Partners Fund VII
Private Equity (PE)
Healthcare Services
Energy
HealthTech
Series B
Late Stage (Series C+)
Australia and others
$5-10 m
$670 M
April 2023

Contacts

Name
Title
Email
avatar
Russell Sinclair Managing Partner - Private Credit
Managing Partner - Private Credit
r•••@•••
avatar
Daren McKennay Partner
Partner
d•••@•••
Upgrade to see contacts
avatar
l27U5fTv9onLRSPr l27U5fTv9onLRSPr
l27U5fTv9onLRSPr
avatar
l27U5fTv9onLRSPr l27U5fTv9onLRSPr
l27U5fTv9onLRSPr
avatar
l27U5fTv9onLRSPr l27U5fTv9onLRSPr
l27U5fTv9onLRSPr
Investment-team contacts for Crescent Capital Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Crescent Capital Partners

Crescent Capital Partners is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $100+ m.
Crescent Capital Partners is located in Sydney, New South Wales, Australia.
Crescent Capital Partners was founded in 2000.
Crescent Capital Partners invests in companies and startups in Consumer Products, Education, Financial Services, Healthcare Services, Industrial, Other, Fintech, Food and Beverage, Foodtech, Energy, HealthTech.
Crescent Capital Partners invests in companies and startups in Australia and others.
Crescent Capital Partners invests in companies and startups at Series B, Late Stage (Series C+).
Crescent Capital Partners usually invests $100+ m on average.
Crescent Capital Partners has around $4 500m assets under management.
Crescent Capital Partners last fund was created/launched in 2023-04-14
Crescent Capital Partners can be reached through its website crescentcap.com.au and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Crescent Capital Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Crescent Capital Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.